Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy InspireMD stock
Learn how to easily invest in InspireMD stock.
InspireMD Inc is a medical devices business based in the US. InspireMD shares (NSPR) are listed on the NASDAQ and all prices are listed in US Dollars. InspireMD employs 45 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in InspireMD
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NSPR – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
InspireMD stock price (NASDAQ: NSPR)Use our graph to track the performance of NSPR stocks over time.
InspireMD shares at a glance
|Latest market close||$2.92|
|52-week range||$2.80 - $22.20|
|50-day moving average||$3.56|
|200-day moving average||$4.74|
|Wall St. target price||$16.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.43|
Buy InspireMD shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy InspireMD stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
InspireMD price performance over time
|1 week (2022-01-06)||-3.63%|
|1 month (2021-12-17)||-13.61%|
|3 months (2021-10-15)||-31.13%|
|6 months (2021-07-16)||-32.41%|
|1 year (2021-01-15)||-67.56%|
|2 years (2020-01-17)||-85.69%|
|3 years (2019-01-17)||120|
|5 years (2017-01-17)||1942.5|
|Revenue TTM||$3.3 million|
|Gross profit TTM||$83,000|
|Return on assets TTM||-30.22%|
|Return on equity TTM||-60.71%|
|Market capitalisation||$24.4 million|
TTM: trailing 12 months
InspireMD share dividends
We're not expecting InspireMD to pay a dividend over the next 12 months.
Have InspireMD's shares ever split?
InspireMD's shares were split on a 1:15 basis on 26 April 2021. So if you had owned 15 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your InspireMD shares – just the quantity. However, indirectly, the new 1400% higher share price could have impacted the market appetite for InspireMD shares which in turn could have impacted InspireMD's share price.
InspireMD share price volatility
Over the last 12 months, InspireMD's shares have ranged in value from as little as $2.8 up to $22.2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while InspireMD's is 1.5286. This would suggest that InspireMD's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
InspireMD, Inc. , a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms and seals the aneurysms. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv, Israel.
InspireMD in the news
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
Two of Sen. Kyrsten Sinema's former aides have lobbied for corporate giants looking to influence Joe Biden's agenda
INSPIREMD, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
Frequently asked questionsWhat percentage of InspireMD is owned by insiders or institutions?
Currently 6.025% of InspireMD shares are held by insiders and 2.107% by institutions. How many people work for InspireMD?
Latest data suggests 45 work at InspireMD. When does the fiscal year end for InspireMD?
InspireMD's fiscal year ends in December. Where is InspireMD based?
InspireMD's address is: 4 Menorat Hamaor Street, Tel Aviv, Israel, 6744832 What is InspireMD's ISIN number?
InspireMD's international securities identification number is: US45779A8466 What is InspireMD's CUSIP number?
InspireMD's Committee on Uniform Securities Identification Procedures number is: 45779A101
More guides on Finder
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Can Turo’s IPO do better than Uber and Airbnb?
Car-sharing service Turo has filed plans for an IPO. What you need to know.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
How to buy Austin Gold (AUST) stock when it goes public
Everything we know about the Austin Gold IPO, plus information on how to buy in.
How to buy VinFast stock when it goes public
Everything we know about the VinFast IPO, plus information on how to buy in.
NFT-funded LinksDAO moves $10.5 million closer to buying a golf course
Creating a golf club is a thus-far unique application of NFTs, and another step forward for the decentralized economy.
How to buy Nexalin Technology (NXL) stock when it goes public
Everything we know about the Nexalin Technology IPO, plus information on how to buy in.
Ask an Expert